You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pazopanib maintenance

Showing 1 - 25 of 5,945
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))

Recruiting
  • Malignant Solid Neoplasms
  • Nilotinib (400 mg BID)
  • +6 more
  • Bordeaux, France
  • +6 more
Dec 15, 2022

Ovarian Cancer Trial in France (Pazopanib, Paclitaxel)

Completed
  • Ovarian Cancer
  • Avignon, France
  • +35 more
Feb 23, 2022

SCLC Trial in Seoul (Pazopanib, Placebo)

Completed
  • SCLC
  • Seoul, Korea, Republic of
    Samsung Medical Center
Dec 5, 2019

Glioblastoma Multiforme Trial in Nice (Pazopanib)

Active, not recruiting
  • Glioblastoma Multiforme
  • Nice, Cedex 2, France
    Centre Antoine Lacassagne
Mar 3, 2022

Hereditary Hemorrhagic Telangiectasia, Epistaxis, Anemia Trial (Pazopanib, Placebo oral capsule)

Not yet recruiting
  • Hereditary Hemorrhagic Telangiectasia
  • +4 more
  • (no location specified)
Aug 17, 2022

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
Has Results
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Soft Tissue Sarcoma Trial (pembrolizumab, pazopanib)

Not yet recruiting
  • Soft Tissue Sarcoma
  • pembrolizumab, pazopanib
  • (no location specified)
Dec 26, 2022

Solid Tumor Trial in Jacksonville, Rochester (Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Pharmacological Study)

Active, not recruiting
  • Solid Neoplasm
  • Laboratory Biomarker Analysis
  • +2 more
  • Jacksonville, Florida
  • +1 more
Jan 25, 2023

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • pazopanib hydrochloride
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 26, 2022

Refractory Solid Tumors Trial in Seoul (pazopanib)

Completed
  • Refractory Solid Tumors
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Refractory Solid Tumors Trial in Seoul (pazopanib)

Completed
  • Refractory Solid Tumors
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Stage IIA Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in Seattle

Completed
Has Results
  • Stage IIA Adult Soft Tissue Sarcoma
  • +2 more
  • Doxorubicin Hydrochloride
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 1, 2020

Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in United

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Ascorbic Acid
  • Pazopanib Hydrochloride
  • Peoria, Illinois
  • +4 more
Mar 18, 2022

Solid Tumors Trial in Canada (Topotecan and Pazopanib)

Completed
  • Solid Tumors
  • Topotecan and Pazopanib
  • Calgary, Alberta, Canada
  • +9 more
Jun 27, 2022

High Grade Sarcoma, Metastatic Leiomyosarcoma, Metastatic Malignant Peripheral Nerve Sheath Tumor Trial in United States

Terminated
Has Results
  • High Grade Sarcoma
  • +18 more
  • Birmingham, Alabama
  • +459 more
Jul 27, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

Recruiting
  • Advanced Soft Tissue Sarcoma
  • +2 more
  • Nanoparticle Albumin-Bound Rapamycin
  • Pazopanib hydrochloride
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Thyroid Gland Anaplastic Carcinoma Trial in United States (radiation, drug, other)

Completed
Has Results
  • Thyroid Gland Anaplastic Carcinoma
  • Intensity-Modulated Radiation Therapy
  • +3 more
  • Birmingham, Alabama
  • +129 more
Jun 28, 2022

Kidney Tumor Trial in France (blood sampling for ITK dosage)

Recruiting
  • Kidney Neoplasm
  • blood sampling for ITK dosage
  • Marseille, France
  • +4 more
Jan 6, 2023

Angiosarcoma Trial in Austria, Germany (Pazopanib + Paclitaxel)

Terminated
Has Results
  • Angiosarcoma
  • Pazopanib + Paclitaxel
  • Graz, Austria
  • +9 more
Jan 21, 2022

Sarcoma Trial in France (Nivolumab and IPILIMUMAB, Pazopanib Oral Tablet [Votrient])

Recruiting
  • Sarcoma
  • Nivolumab and IPILIMUMAB
  • Pazopanib Oral Tablet [Votrient]
  • Lyon, Rhône, France
  • +10 more
Jun 22, 2022

Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

Active, not recruiting
  • Renal Cell Carcinoma
  • Perfusion CT scan
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Lichen Sclerosus Trial in Winterthur (Treatment with Monalisa Glide Laser, Treatment with Clobetasol)

Recruiting
  • Lichen Sclerosus
  • Treatment with Monalisa Glide Laser
  • Treatment with Clobetasol
  • Winterthur, Zürich, Switzerland
    Kantonsspital Winterthur
Nov 14, 2023

Autoimmune Diseases Trial in Beijing (, mycophenolate mofetil)

Not yet recruiting
  • Autoimmune Diseases
  • placebo
  • mycophenolate mofetil
  • Beijing, China
    Peking Union Medical College Hospital
Jul 26, 2023